Featured,Trends & Articles New York Legislators Proposes Bills to Decriminalize Psychedelics By Dennis Mutua May 09, 2022 New York legislators have come up with several bills which are seeking to decriminalize use of psychedelic substances across the state. The bills were introduced late last week. Psychedelics is currently considered a Schedule I co...
Featured,Trends & Articles Canada Financing Research on Psilocybin Treatment for Substance Use Disorder By Dennis Mutua May 06, 2022 The Canadian Institute of Health Research (CIHR), a federal agency will be funding three grant recipients to research on psilocybin treatments for substance use disorder (SUD), depression and end-of-life distress. This grant wi...
Featured,Spotlight Stock,Trends & Articles Field Trip to Spin Off Into Two Separate Publicly Traded Companies By Dennis Mutua May 02, 2022 Psychedelics company focusing on development and delivery of technology enabled psychedelic therapies Field Trip Health Ltd. (NASDAQ: FTRP) (TSE: FTRP) announced that it will be separating into two divisions which will both be pub...
Featured,Spotlight Stock,Trends & Articles Optimi Health Completes Largest GMP-Grade Licensed Psilocybin Cultivation Facility in Canada By Dennis Mutua April 29, 2022 Psychedelics company engaging in development, cultivation, extraction, processing and distribution of functional mushrooms Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) announced that it will be officially launching its recently ...
Featured,Trends & Articles Advocates in Texas Pushing for Psychedelic Therapies Following Veteran Suicides Increase By Dennis Mutua April 25, 2022 A group of veteran advocates and organizations are pushing for the state governments to consider psychedelic treatments following an increase of veteran suicides in Texas. Citing recently released federal data, about 10 veterans f...
Featured,Trends & Articles Cannsun Granted Regulatory Approval to Conduct Phase 2 Psilocybin Trials in Africa By Dennis Mutua April 15, 2022 Bio-pharmaceutical company focusing on developing and commercializing new medicines to optimize human health Cannsun Group PLC announced having been granted regulatory approval by the South African Health Products Regulatory Autho...
Featured,Spotlight Stock,Trends & Articles Numinus Inks Deal to Acquire Novamind in What Will Become Biggest Psychedelics Merger By Dennis Mutua April 13, 2022 Mental health and wellness company combining the practices of administering psychedelics medicine with holistic integrated psychotherapy Numinus Wellness Inc. (TSX: NUMI) (OTCMKTS: NUMIF) has signed a deal agreeing to acquire fell...
Featured,Trends & Articles Maryland Sends Bill to Fund Psychedelics Access by Veterans to Governor’s Desk By Dennis Mutua April 12, 2022 At the end of last week, legislators from Maryland send a bill which would create a state fund to fund cost-free access to psychedelics for military veterans suffering from brain injury and post-traumatic stress disorder (PTSD) to...
